Researchers at Yale School of Medicine have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug recently shown to reverse two other disfiguring skin conditions, vitiligo and alopecia areata. The study is evidence...
Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.The finding, published Aug. 27 in PLOS ONE,...
Antibiotics and other antimicrobials are often administered to terminally ill patients. But given widespread concern about antibiotic resistance, this common practice should be reconsidered by providers, patients, and families, according to a Yale...